Sign up to save your podcasts
Or
Share What’s new in primary ITP? Key updates from ASH 2024
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What’s new in primary ITP? Key updates from ASH 2024
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#
View all episodes
By touchpodcasttouchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#